Anuj Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anuj Kumar has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
Pramod Kumar
6 shared publications- Pramod Kumar
Division of Molecular Biology, Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research
6 shared publications Ritu Sagar
5 shared publications- Amit Sharma
Affiliation Molecular Medicine Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India
4 shared publications Shalini Singh
National Institute of Cancer Prevention and Research, Indian Council for Medical Research (ICMR-NICPR), Noida, India
4 shared publications- Rajlakshmi Viswanathan
ICMR-National Institute of Virology. Microbial Containment Complex, Pune, Maharashtra, India
3 shared publications
Latest Publications
- 13 November 2026
- Published by Elsevier in Seminars in Oncology
Interplay of Oncogenic Pathways in Colorectal Cancer: Mechanisms Driving Progression and Drug Resistance
- 13 November 2026
- Published by Elsevier in Seminars in Oncology
Interplay of Oncogenic Pathways in Colorectal Cancer: Mechanisms Driving Progression and Drug Resistance
- Open Access
- 3 October 2026
- Published by Center for Open Science in OSF Preprints
Molecular Interactions of Flavour Compounds in Smokeless Tobacco: A Bioinformatics Analysis of Gene Networks and Health Implications
Smokeless tobacco (SLT) products increasingly incorporate flavour additives that enhance palatability and potentially influence addiction liability. This study investigates the molecular mechanisms through which eight commonly used flavour compounds interact with human genes and biological pathways. Using systematic bioinformatics approaches, we analyzed protein-chemical interactions through the STITCH database and functional enrichment was then carried out with PANTHER, g:Profiler, and Enrichr-KG to identify pathways and disease associations.” Our analysis identified 56 human genes across 35 gene families that interact with these flavour compounds. Key findings reveal that vanillin, menthol, and eugenol significantly modulate genes involved in calcium signaling (TRPV1, TRPA1), xenobiotic metabolism (UGT1A subfamily), and neurotransmitter pathways. Functional enrichment analysis demonstrated that these compounds influence critical biological processes including detoxification mechanisms, thermal sensation, inflammatory responses, and ion channel activities. Notably, menthol and eucalyptol showed strong associations with ligand-gated calcium channels, while vanillin exhibited enhanced glucuronidation activities. The identified gene networks suggest potential mechanisms by which flavour additives may contribute to tobacco dependence and physiological harm beyond their sensory effects. These findings provide molecular evidence supporting the need for comprehensive regulatory evaluation of flavour additives in tobacco products and highlight specific biological targets for future toxicological assessments.
- 3 October 2026
- Published by Center for Open Science in OSF Preprints
Open AccessMolecular Interactions of Flavour Compounds in Smokeless Tobacco: A Bioinformatics Analysis of Gene Networks and Health Implications
Smokeless tobacco (SLT) products increasingly incorporate flavour additives that enhance palatability and potentially influence addiction liability. This study investigates the molecular mechanisms through which eight commonly used flavour compounds interact with human genes and biological pathways. Using systematic bioinformatics approaches, we analyzed protein-chemical interactions through the STITCH database and functional enrichment was then carried out with PANTHER, g:Profiler, and Enrichr-KG to identify pathways and disease associations.” Our analysis identified 56 human genes across 35 gene families that interact with these flavour compounds. Key findings reveal that vanillin, menthol, and eugenol significantly modulate genes involved in calcium signaling (TRPV1, TRPA1), xenobiotic metabolism (UGT1A subfamily), and neurotransmitter pathways. Functional enrichment analysis demonstrated that these compounds influence critical biological processes including detoxification mechanisms, thermal sensation, inflammatory responses, and ion channel activities. Notably, menthol and eucalyptol showed strong associations with ligand-gated calcium channels, while vanillin exhibited enhanced glucuronidation activities. The identified gene networks suggest potential mechanisms by which flavour additives may contribute to tobacco dependence and physiological harm beyond their sensory effects. These findings provide molecular evidence supporting the need for comprehensive regulatory evaluation of flavour additives in tobacco products and highlight specific biological targets for future toxicological assessments.
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Genetic Factors Influencing Tobacco Cessation
Research into multi-causative disorders, such as substance dependence, makes it important to understand their neurobiological, genetic, and environmental foundations. The primary objective is to study the dynamic relationship of these factors to combat global health concerns like cancer, emphysema, asthma etc. Our research focuses on developing and applying precision preclinical models to investigate these disorders. It employs the use of bioinformatics and computational biology tools, including machine learning and AI-based methodologies such as UMAP (Uniform Manifold Approximation and Projection) using PYTHON and its libraries. Specifically, a structure-based functional analysis of sixteen genes associated with nicotine dependence has been performed using PDB, ChimeraX and BLAST for Structural Bioinformatics, visualization and Sequence Alignment respectively. We found CHRNA5, exhibited maximum number of polymorphisms while MAOA's methylation is implicated. Nicotine dependence involves genetic variants in CHRNA5-CHRNA3-CHRNA4 gene cluster affecting dopaminergic systems, alongside DRD2, DAT1, COMT, and CYP2A6. GABAergic receptor subunits (e.g., GABRA2, GABBR1) contain conserved domains that regulate inhibitory neurotransmission relevant to nico?ne dependence, base sequence changes in genes such as MAOA, MAOB, DAT1, DRD1, and GABA, COMT enzyme activity, influenced by the Val158Met polymorphism, modulates dopamine neurotransmission and effects nicotine susceptibility, with sex-specific differences noticed.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessGenetic Factors Influencing Tobacco Cessation
Research into multi-causative disorders, such as substance dependence, makes it important to understand their neurobiological, genetic, and environmental foundations. The primary objective is to study the dynamic relationship of these factors to combat global health concerns like cancer, emphysema, asthma etc. Our research focuses on developing and applying precision preclinical models to investigate these disorders. It employs the use of bioinformatics and computational biology tools, including machine learning and AI-based methodologies such as UMAP (Uniform Manifold Approximation and Projection) using PYTHON and its libraries. Specifically, a structure-based functional analysis of sixteen genes associated with nicotine dependence has been performed using PDB, ChimeraX and BLAST for Structural Bioinformatics, visualization and Sequence Alignment respectively. We found CHRNA5, exhibited maximum number of polymorphisms while MAOA's methylation is implicated. Nicotine dependence involves genetic variants in CHRNA5-CHRNA3-CHRNA4 gene cluster affecting dopaminergic systems, alongside DRD2, DAT1, COMT, and CYP2A6. GABAergic receptor subunits (e.g., GABRA2, GABBR1) contain conserved domains that regulate inhibitory neurotransmission relevant to nico?ne dependence, base sequence changes in genes such as MAOA, MAOB, DAT1, DRD1, and GABA, COMT enzyme activity, influenced by the Val158Met polymorphism, modulates dopamine neurotransmission and effects nicotine susceptibility, with sex-specific differences noticed.
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Identification of Genetic Factors Associated With Nicotine Addiction and Cancer
Cancer is the greatest cause of mortality, and tobacco smoking has been identified as the most significant risk factor for developing oral cancer. Nicotine is a primary addictive constituent of tobacco, and it is responsible for the development of cigarette addiction by stimulating the nicotinic receptor, which promotes the release of neurotransmitters in the brain, giving the smoker a pleasurable experience. A preponderance of evidence supports that tobacco smoking is the most important leading cause of cancer which is preventable. Tobacco cessation is a key component of a comprehensive approach to prevent and reduce tobacco use and save people from cancer. However, cessation programs are not found that efficient.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessIdentification of Genetic Factors Associated With Nicotine Addiction and Cancer
Cancer is the greatest cause of mortality, and tobacco smoking has been identified as the most significant risk factor for developing oral cancer. Nicotine is a primary addictive constituent of tobacco, and it is responsible for the development of cigarette addiction by stimulating the nicotinic receptor, which promotes the release of neurotransmitters in the brain, giving the smoker a pleasurable experience. A preponderance of evidence supports that tobacco smoking is the most important leading cause of cancer which is preventable. Tobacco cessation is a key component of a comprehensive approach to prevent and reduce tobacco use and save people from cancer. However, cessation programs are not found that efficient.
- Open Access
- 13 July 2026
- Published by Elsevier in SSRN Electronic Journal
Molecular Interactions of Flavour Compounds in Smokeless Tobacco: A Bioinformatics Analysis of Gene Networks and Health Implications
Smokeless tobacco (SLT) products increasingly incorporate flavour additives that enhance palatability and potentially influence addiction liability. This study investigates the molecular mechanisms through which eight commonly used flavour compounds interact with human genes and biological pathways. Using systematic bioinformatics approaches, we analyzed protein-chemical interactions through the STITCH database and functional enrichment was then carried out with PANTHER, g:Profiler, and Enrichr-KG to identify pathways and disease associations." Our analysis identified 56 human genes across 35 gene families that interact with these flavour compounds. Key findings reveal that vanillin, menthol, and eugenol significantly modulate genes involved in calcium signaling (TRPV1, TRPA1), xenobiotic metabolism (UGT1A subfamily), and neurotransmitter pathways. Functional enrichment analysis demonstrated that these compounds influence critical biological processes including detoxification mechanisms, thermal sensation, inflammatory responses, and ion channel activities. Notably, menthol and eucalyptol showed strong associations with ligand-gated calcium channels, while vanillin exhibited enhanced glucuronidation activities. The identified gene networks suggest potential mechanisms by which flavour additives may contribute to tobacco dependence and physiological harm beyond their sensory effects. These findings provide molecular evidence supporting the need for comprehensive regulatory evaluation of flavour additives in tobacco products and highlight specific biological targets for future toxicological assessments.
- 13 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMolecular Interactions of Flavour Compounds in Smokeless Tobacco: A Bioinformatics Analysis of Gene Networks and Health Implications
Smokeless tobacco (SLT) products increasingly incorporate flavour additives that enhance palatability and potentially influence addiction liability. This study investigates the molecular mechanisms through which eight commonly used flavour compounds interact with human genes and biological pathways. Using systematic bioinformatics approaches, we analyzed protein-chemical interactions through the STITCH database and functional enrichment was then carried out with PANTHER, g:Profiler, and Enrichr-KG to identify pathways and disease associations." Our analysis identified 56 human genes across 35 gene families that interact with these flavour compounds. Key findings reveal that vanillin, menthol, and eugenol significantly modulate genes involved in calcium signaling (TRPV1, TRPA1), xenobiotic metabolism (UGT1A subfamily), and neurotransmitter pathways. Functional enrichment analysis demonstrated that these compounds influence critical biological processes including detoxification mechanisms, thermal sensation, inflammatory responses, and ion channel activities. Notably, menthol and eucalyptol showed strong associations with ligand-gated calcium channels, while vanillin exhibited enhanced glucuronidation activities. The identified gene networks suggest potential mechanisms by which flavour additives may contribute to tobacco dependence and physiological harm beyond their sensory effects. These findings provide molecular evidence supporting the need for comprehensive regulatory evaluation of flavour additives in tobacco products and highlight specific biological targets for future toxicological assessments.
- Open Access
- 14 June 2026
- Published by Elsevier in SSRN Electronic Journal
Circulating Histone Chaperone Profiles As Novel Biomarkers for Early Lung Cancer Detection and Their Exploitation in Liquid Biopsies
Lung cancer is substantial burden to health infrastructure around the world. Lung cancer diagnosis is challenging due to late-stage detection and false diagnosis. Thus, there is a need to discover novel biomarker for early detection. There is a growing potential of circulating DNA, histones and histone chaperones as innovative biomarkers in the early detection and prognosis of lung cancer. Although the field is still in its formative stages, preliminary findings suggest that alterations in the levels of circulating histone chaperones, such as ASF-1, may serve as valuable indicators of the dynamic interactions between tumor cells and the surrounding microenvironment. These interactions could provide critical insights into tumor progression, potentially revealing early signs of malignancy before conventional diagnostic methods become effective. However, much more research is needed to fully understand the underlying mechanisms that govern the release of histone chaperones into the bloodstream. Additionally, a deeper investigation into their precise roles in tumorigenesis and their potential impact on cancer biology is essential for assessing their utility as reliable biomarkers. At present, these biomarkers hold promise, but their clinical application requires further validation through rigorous, largescale studies that can confirm their diagnostic and prognostic capabilities. Key to realizing the clinical potential of circulating histone chaperones will be the development of highly sensitive and specific assays capable of detecting and quantifying these biomarkers with accuracy. Furthermore, advances in liquid biopsy technologies, which offer non-invasive alternatives to traditional tissue biopsies, will play a pivotal role in enabling the widespread use of circulating histone chaperones in routine clinical practice.
- 14 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessCirculating Histone Chaperone Profiles As Novel Biomarkers for Early Lung Cancer Detection and Their Exploitation in Liquid Biopsies
Lung cancer is substantial burden to health infrastructure around the world. Lung cancer diagnosis is challenging due to late-stage detection and false diagnosis. Thus, there is a need to discover novel biomarker for early detection. There is a growing potential of circulating DNA, histones and histone chaperones as innovative biomarkers in the early detection and prognosis of lung cancer. Although the field is still in its formative stages, preliminary findings suggest that alterations in the levels of circulating histone chaperones, such as ASF-1, may serve as valuable indicators of the dynamic interactions between tumor cells and the surrounding microenvironment. These interactions could provide critical insights into tumor progression, potentially revealing early signs of malignancy before conventional diagnostic methods become effective. However, much more research is needed to fully understand the underlying mechanisms that govern the release of histone chaperones into the bloodstream. Additionally, a deeper investigation into their precise roles in tumorigenesis and their potential impact on cancer biology is essential for assessing their utility as reliable biomarkers. At present, these biomarkers hold promise, but their clinical application requires further validation through rigorous, largescale studies that can confirm their diagnostic and prognostic capabilities. Key to realizing the clinical potential of circulating histone chaperones will be the development of highly sensitive and specific assays capable of detecting and quantifying these biomarkers with accuracy. Furthermore, advances in liquid biopsy technologies, which offer non-invasive alternatives to traditional tissue biopsies, will play a pivotal role in enabling the widespread use of circulating histone chaperones in routine clinical practice.
- 6 May 2026
- Published by Elsevier in Pharmacological Research - Natural Products
- Vol. 11
Clinical utility of bioactive metabolites of medicinal mushrooms in colorectal cancer
- 6 May 2026
- Published by Elsevier in Pharmacological Research - Natural Products
- Vol. 11
Clinical utility of bioactive metabolites of medicinal mushrooms in colorectal cancer
- Open Access
- 23 April 2026
- Published by EDP Sciences in BIO Web of Conferences
- Vol. 233, 01007
Designing Therapeutic Peptides for Inhibiting the mTORC1 Signalling Pathway: A Novel Trend in Cancer Therapeutics
Cancer is the second leading cause of death globally, characterized by hallmark features including uncontrolled cell proliferation, enhanced survival, abnormal angiogenesis, immune evasion, and metabolic reprogramming. The mTOR signalling pathway intersects with all these hallmarks, positioning it as an attractive therapeutic target. One promising approach involves disrupting protein-protein interactions using peptides derived from interfacial amino acids of binding partners. This study employed such a strategy to inhibit the association between mTOR kinase and RHEB, a critical interaction for mTORC1 activation. Three native peptides were designed from the mTOR-RHEB interface sequence. These were further modified by incorporating evolutionarily conserved mutations observed in mTOR sequences. All peptides were evaluated for binding affinity with RHEB through protein-peptide docking using HADDOCK 2.4 and binding energy calculations via FoldX5.0. Interaction analyses were performed using LigPlot+. The peptides were designated N1-3 (native), M1-3 (mutated), and C1-3 (control). Among these, peptides M2 and M3 demonstrated binding energies of -14.28 kcal/mol and -14.53 kcal/mol, respectively, comparable to the complete mTOR-RHEB complex (-15.83 kcal/mol). These findings were supported by extensive hydrogen bonding and favourable intermolecular interactions. The results suggest that these peptides possess significant potential to disrupt mTORC1 signalling, warranting further validation through in vitro studies for cancer therapeutic applications.
- 23 April 2026
- Published by EDP Sciences in BIO Web of Conferences
- Vol. 233, 01007
Open AccessDesigning Therapeutic Peptides for Inhibiting the mTORC1 Signalling Pathway: A Novel Trend in Cancer Therapeutics
Cancer is the second leading cause of death globally, characterized by hallmark features including uncontrolled cell proliferation, enhanced survival, abnormal angiogenesis, immune evasion, and metabolic reprogramming. The mTOR signalling pathway intersects with all these hallmarks, positioning it as an attractive therapeutic target. One promising approach involves disrupting protein-protein interactions using peptides derived from interfacial amino acids of binding partners. This study employed such a strategy to inhibit the association between mTOR kinase and RHEB, a critical interaction for mTORC1 activation. Three native peptides were designed from the mTOR-RHEB interface sequence. These were further modified by incorporating evolutionarily conserved mutations observed in mTOR sequences. All peptides were evaluated for binding affinity with RHEB through protein-peptide docking using HADDOCK 2.4 and binding energy calculations via FoldX5.0. Interaction analyses were performed using LigPlot+. The peptides were designated N1-3 (native), M1-3 (mutated), and C1-3 (control). Among these, peptides M2 and M3 demonstrated binding energies of -14.28 kcal/mol and -14.53 kcal/mol, respectively, comparable to the complete mTOR-RHEB complex (-15.83 kcal/mol). These findings were supported by extensive hydrogen bonding and favourable intermolecular interactions. The results suggest that these peptides possess significant potential to disrupt mTORC1 signalling, warranting further validation through in vitro studies for cancer therapeutic applications.
- Open Access
- 7 April 2026
- Published by Springer Nature in Research Square
Identification of genetic factors associated with nicotine addiction and cancer
Cancer is the greatest cause of mortality, and tobacco smoking has been identified as the most significant risk factor for developing oral cancer. Nicotine is a primary addictive constituent of tobacco, and it is responsible for the development of cigarette addiction by stimulating the nicotinic receptor, which promotes the release of neurotransmitters in the brain, giving the smoker a pleasurable experience. A preponderance of evidence supports that tobacco smoking is the most important leading cause of cancer which is preventable. Tobacco cessation is a key component of a comprehensive approach to prevent and reduce tobacco use and save people from cancer. However, cessation programs are not found that efficient. The goal of this study was to provide an overview of smoking and the complexities of dependency, with a focus on the role of genetic factors, such as enzymes involved in nicotine metabolism and how genetic polymorphism, such as SNP (Single Nucleotide Polymorphism), plays in the development of nicotine addiction.
- 7 April 2026
- Published by Springer Nature in Research Square
Open AccessIdentification of genetic factors associated with nicotine addiction and cancer
Cancer is the greatest cause of mortality, and tobacco smoking has been identified as the most significant risk factor for developing oral cancer. Nicotine is a primary addictive constituent of tobacco, and it is responsible for the development of cigarette addiction by stimulating the nicotinic receptor, which promotes the release of neurotransmitters in the brain, giving the smoker a pleasurable experience. A preponderance of evidence supports that tobacco smoking is the most important leading cause of cancer which is preventable. Tobacco cessation is a key component of a comprehensive approach to prevent and reduce tobacco use and save people from cancer. However, cessation programs are not found that efficient. The goal of this study was to provide an overview of smoking and the complexities of dependency, with a focus on the role of genetic factors, such as enzymes involved in nicotine metabolism and how genetic polymorphism, such as SNP (Single Nucleotide Polymorphism), plays in the development of nicotine addiction.
- Open Access
- 6 January 2026
- Published by Springer Nature in Research Square
In-silico Identification of Potential Therapeutic Targets against Virus Induced Hepatocellular Carcinoma
Background Chemo resistance in hepatocellular carcinoma is a challenge that leads to a high mortality rate. The discovery of novel drugs and drug targets is crucial to develop combination therapy. The study reports drug targets based on an ‘omics’-based approach and studied in silico binding of bufalin compound to potential drug target. Method Gene expression data sets from tumours of HCC patients were compared with that of health control. Differentially expressed genes in tumour tissues were analysed for gene ontology and metabolic pathways. Hub genes were identified using a network biology approach and studied as potential drug targets. Result A total of 104 common genes were identified from 3 datasets, from which 54 genes were upregulated and 50 genes were downregulated. Ten Hub genes were identified, which were all over-expressed in the tumour tissues and correlated with poor survival rates. Molecular docking result suggests Hub protein thymidylate synthase binding to anticancer agent bufalin. Conclusion A total of 10 potential anti-cancer therapeutic targets were identified using ‘omics’ and network biology approach. Among that thymidylate synthase was binding with a potential anti-cancer drug bufalin.
- 6 January 2026
- Published by Springer Nature in Research Square
Open AccessIn-silico Identification of Potential Therapeutic Targets against Virus Induced Hepatocellular Carcinoma
Background Chemo resistance in hepatocellular carcinoma is a challenge that leads to a high mortality rate. The discovery of novel drugs and drug targets is crucial to develop combination therapy. The study reports drug targets based on an ‘omics’-based approach and studied in silico binding of bufalin compound to potential drug target. Method Gene expression data sets from tumours of HCC patients were compared with that of health control. Differentially expressed genes in tumour tissues were analysed for gene ontology and metabolic pathways. Hub genes were identified using a network biology approach and studied as potential drug targets. Result A total of 104 common genes were identified from 3 datasets, from which 54 genes were upregulated and 50 genes were downregulated. Ten Hub genes were identified, which were all over-expressed in the tumour tissues and correlated with poor survival rates. Molecular docking result suggests Hub protein thymidylate synthase binding to anticancer agent bufalin. Conclusion A total of 10 potential anti-cancer therapeutic targets were identified using ‘omics’ and network biology approach. Among that thymidylate synthase was binding with a potential anti-cancer drug bufalin.